Literature DB >> 700256

Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.

P L Werner, J P Palmer.   

Abstract

In a group of pancreatectomized subjects, immunoreactive glucagon (IRG) concentrations were normal after an overnight fast, increased after oral glucose, were not suppressed by somatostatin (SRIF) or insulin, and in two of four subjects they rose with an arginine infusion. Even though the SRIF infusion failed to lower IRG, there was a fall in plasma glucose concentration in both subjects. In two subjects, endogenous hyperglycemia occurred during insulin withdrawal without a rise in IRG, and, in one subject, mild diabetic ketoacidosis developed with only a minimal rise in IRG. These results support the presence of an extrapancreatic source of IRG in man. Secretion from these extrapancreatic alpha cells appears to be regulated differently than secretion from pancreatic alpha cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 700256     DOI: 10.2337/diab.27.10.1005

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 2.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

3.  Absence of islet alpha cell function in pancreatectomized patients.

Authors:  A Tiengo; M Bessioud; I Valverde; A Tabbi-Anneni; S Delprato; J Alexandre; R Assan
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

4.  How does glucose regulate the human pancreatic A cell in vivo?

Authors:  C M Asplin; P M Hollander; J P Palmer
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

5.  In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.

Authors:  C M Asplin; T L Paquette; J P Palmer
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Changes in plasma glucagon after total pancreatectomy in man.

Authors:  T Sudo; T Suzuki; T Tobe
Journal:  Gastroenterol Jpn       Date:  1980

7.  Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis.

Authors:  S Del Prato; F Riva; A Devidé; R Nosadini; D Fedele; A Tiengo
Journal:  Acta Diabetol Lat       Date:  1980 Apr-Jun

8.  Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).

Authors:  F Santeusanio; M Massi-Benedetti; G Angeletti; G Calabrese; A Bueti; P Brunetti
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

9.  Effects of total pancreatectomy on the secretion of gut glucagon in humans.

Authors:  K Yasui
Journal:  Jpn J Surg       Date:  1983-03

10.  Abnormal regulation of pancreatic glucagon secretion in obese fa/fa rats.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.